Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 6/20 | 0.68 |
| ▸ | LMNA | P02545 | 5/20 | 0.68 |
| ▸ | RECQL | P46063 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.65 |
| ▸ | HTT | P42858 | 3/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14963037 | 1.00 | MAPT (1.00) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL4065161 | 1.00 | MAPT (1.00) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| Hydrochloric Acid SCHEMBL16147136 | 0.98 | MAPT (0.96) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL23251385 | 0.90 | MAPT (0.81) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL12914243 | 0.82 | MAPT (0.70) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL801273 | 0.82 | MAPT (0.70) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL1186588 | 0.82 | MAPT (0.70) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL7364598 | 0.82 | MAPT (0.70) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL1186589 | 0.82 | MAPT (0.70) | MAPTHPGDCYP1A2CYP2C19ALOX12 | |
| SCHEMBL4894903 | 0.82 | RECQL (0.75) | MAPTHPGDCYP1A2CYP2C19ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080001-A | Perfluoroalkyl substituted pyrimido [1,2-b ] indazole ketone compound and preparation method thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-119900035-A | Method for synthesizing 2, 5-disubstituted furan by C-C double bond cleavage free radical tandem electricity | 南京工业大学 | 2025-04-29 | — | — | CN | disclosed |
| CN-119330879-A | Synthesis method of quinoline compound | 江南大学 | 2025-01-21 | — | — | CN | disclosed |
| CN-119241430-A | Dihydroquinolines method for synthesizing compound | 无锡学院 | 2025-01-03 | — | — | CN | disclosed |
| CN-116240560-A | Method for electrochemically synthesizing furoquinone by utilizing microchannel reactor | 南京工业大学 | 2023-06-09 | — | — | CN | disclosed |
| US-20170121344-A1 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | SIGA TECHNOLOGIES, INC. (US) | 2017-05-04 | — | — | US | disclosed |
| WO-2016096942-A1 | USE OF SELECTED PYRIDONE CARBOXAMIDES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-23 | — | — | WO | disclosed |
| US-8962834-B2 | Modulators of amyloid beta | HOFFMANN-LA ROCHE INC. (US) | 2015-02-24 | — | — | US | disclosed |
| EP-2257541-B1 | MODULATORS FOR AMYLOID BETA | HOFFMANN LA ROCHE (CH) | 2013-08-14 | — | — | EP | disclosed |
| US-20130190302-A1 | MODULATORS OF AMYLOID BETA | HOFFMANN-LA ROCHE INC. (US) | 2013-07-25 | — | — | US | disclosed |
| EP-0672035-A1 | PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995009847-A1 | PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1995-04-13 | — | — | WO | disclosed |
| US-4904658-A | Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-ones | AMERICAN CYANAMID COMPANY (US) | 1990-02-27 | — | — | US | disclosed |
| US-4888345-A | HYPOTENSIVE AND ANXIOLYTIC AGENTS; CHEMICAL INTERMEDIATES | AMERICAN CYANAMID COMPANY (US) | 1989-12-19 | — | — | US | disclosed |
| US-4847256-A | HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1989-07-11 | — | — | US | disclosed |
| US-4755599-A | 3-phenyl-2-propeneamine derivatives, their preparation and composition containing them | RHONE-POULENC SANTE (FR) | 1988-07-05 | — | — | US | disclosed |
| EP-0264773-A1 | 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines | AMERICAN CYANAMID COMPANY (US) | 1988-04-27 | — | — | EP | disclosed |
| US-4686309-A | ANTIDEPRESSANTS | RHONE-POULENC SANTE (FR) | 1987-08-11 | — | — | US | disclosed |
| US-4209621-A | TRANQUILIZERS | AMERICAN CYANAMID COMPANY (US) | 1980-06-24 | — | — | US | disclosed |
| US-4175087-A | ENAMINOKETONES WITH ALKYLLITHIUM | ELI LILLY AND COMPANY (US) | 1979-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121344-A1 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | TTPA, TPMT, SLC19A2 | MAPT 85/4885HPGD 205/4885CYP1A2 1330/4885 |
| US-20130190302-A1 | MODULATORS OF AMYLOID BETA | APP, PSEN1, APOB | MAPT 24/4885HPGD 186/4885CYP1A2 4006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.